Updated on December 23, 2017
Rophe Pharma Announces Eyebrow Growth
Rophe Pharma submitted a press release this week announcing its topical hair growth drug has shown positive results for restoring eyebrows. Rophe’s hair growth candidate RPHE-7193 is a topical form of the FDA approved blood pressure drug hydralazine. The drug apparently has a similar mechanism to minoxidil. Here’s a quote from the press release which was featured on Yahoo News:
“Rophe Pharma researchers analyzed results of RPHE-7193 in women suffering from thinning eyebrows and were amazed by the positive results. Since cosmetic treatments do not provide satisfactory results and are usually a temporary remedy it seems the efficacy of RPHE-71093 in helping women to gain their own eyebrows back could become the most preferred option for restoring hair growth in this area. Encouraged by these results, the company has also initiated an exploratory study to evaluate if RPHE-7193 can stimulate the growth of eyelashes in women. The results will be announced shortly.”
I’m hoping for photos of RPHE-7193’s results in scalp hair growth and eyebrow growth to be released soon. Documented images would certainly add to the interest in RPHE-7193. For more information contact Robert Gadimian, CEO of Rophe Pharma.